Search
for
Sort by
Research 421–450 of 1000+
- Baricitinib for alopecia areata
- 32237 Clinician and patient evaluation of improvement for eyebrow and eyelashes hair loss during baricitinib phase 3 trials BRAVE-AA1 and BRAVE-AA2
- EE325 Budget Impact of Baricitinib for Patients with Severe Alopecia Areata
- <i>JAMA Dermatology—</i>The Year in Review, 2021
- Tofacitinib therapy for the treatment of alopecia areata: Report of 11 patients
- PSS20 MEDIATION MODELING AND MEASUREMENT CHARACTERISTICS OF THE ITCH SEVERITY SCORE FROM A PHASE 2B TRIAL OF ORAL CP-690-550 IN PATIENTS WITH MODERATE TO-SEVERE PLAQUE PSORIASIS
- The JAK/STAT signaling pathway: from bench to clinic
- SOCS1 and SOCS3 as key checkpoint molecules in the immune responses associated to skin inflammation and malignant transformation
- Alopecia areata – Current understanding and management
- JAK-STAT1 as therapeutic target for EGFR deficiency-associated inflammation and scarring alopecia
- The Role of Tofacitinib in the Management of Alopecia Totalis
- Treatment of Crohn's Disease and Concomitant Alopecia Areata With Tofacitinib
- 59 Scarring alopecia is driven by the collapse of EGFR-protected JAK-STAT1-sensitive stem cell immune privilege
- An Overview about Alopecia Areata Etiopathogenesis, Diagnosis, and Management: Review Article
- Ritlecitinib: Efficacy of a Novel Therapy for Severe Alopecia Areata in Patients Aged 12 Years and Older
- S116 Treatment of Concomitant Alopecia Areata and Crohn’s Disease in a Young Child With Tofacitinib: Case Report
- Upadacitinib for the treatment of alopecia areata and severe atopic dermatitis in a paediatric patient: A case report
- Upadacitinib for management of recalcitrant alopecia areata: A retrospective case series
- Clinical Outcomes for Uptitration of Baricitinib Therapy in Patients With Severe Alopecia Areata
- Tofacitinib for the treatment of severe alopecia areata and variants: A retrospective cohort study of 90 patients
- Autophagy Stimulation Improves Erythroid Proliferative Capacity in Models of SF3B1 Mutant MDS
- Les Rencontres d’Experts du Psoriasis : des recommandations pour la pratique quotidienne
- Successful treatment of concomitant alopecia universalis and Crohn’s disease with upadacitinib: A case report
- New Treatment Strategies in Management of Alopecia Areata: Review Article
- Characteristics and Management of Patients with Alopecia Areata and Selected Comorbid Conditions: Results from a Survey in Five European Countries
- Effectiveness of Baricitinib on Nail Alopecia Areata: A 48-Week Single-Center Retrospective Study
- Tofacitinib for the Treatment of Three Immune-mediated Conditions in One Patient: Ulcerative Colitis, Pyoderma Gangrenosum, and Alopecia Areata
- Approach to Managing Recalcitrant Alopecia Areata with Combination Therapy: A Series of Five Cases in Black Pediatric Patients
- A description of alopecia areata in European patients based on real-world survey data: physician-reported characterization of severity and associated treatment utilization
- Selective Janus kinase 1 inhibition resolves inflammation and restores hair growth offering a viable treatment option for alopecia areata